Lacrimal Gland Tumor
Lacrimal gland tumors are abnormal growths arising from the gland responsible for producing the watery component of tears. These tumors may be benign or malignant and can cause upper outer eyelid swelling, orbital fullness, pain, double vision, or changes in eye position depending on their size and behavior.
What Is a Lacrimal Gland Tumor?
A lacrimal gland tumor is an abnormal growth that develops within the lacrimal gland, located in the upper outer portion of the orbit.
The lacrimal gland produces the aqueous layer of the tear film, which provides lubrication, protection, and nourishment to the ocular surface.
Tumors of the lacrimal gland may arise from glandular epithelial cells, lymphoid tissue, inflammatory processes, or metastatic disease.
Some tumors grow slowly over many years, while others may enlarge rapidly and invade surrounding orbital structures.
Lacrimal Gland Anatomy
Understanding lacrimal gland anatomy helps explain how tumors affect the eye and surrounding orbital structures.
Main Lacrimal Gland
Located in the superolateral orbit and responsible for tear secretion.
Orbital Lobe
The larger portion situated within the lacrimal fossa.
Palpebral Lobe
The smaller portion extending toward the upper eyelid.
Lacrimal Duct System
Channels that transport tears from the gland to the ocular surface.
Normal Lacrimal Gland Function
The lacrimal gland plays an essential role in maintaining a healthy tear film.
Aqueous Tear Production
Produces the watery component of tears.
Ocular Surface Protection
Provides moisture and immune protection.
Tear Film Stability
Supports clear vision and ocular comfort.
Defense Against Infection
Contains protective proteins and immune components.
Understanding Lacrimal Gland Tumors
Lacrimal gland tumors develop when abnormal cells grow uncontrollably within the gland or surrounding tissues.
Cellular Growth Abnormality
Normal control of cell division becomes disrupted.
Mass Formation
The growing lesion may enlarge within the confined orbit.
Orbital Pressure Effects
Expansion may push the eye forward or downward.
Tissue Invasion
Malignant tumors may invade nearby structures.
How Lacrimal Gland Tumors Develop
The development of a lacrimal gland tumor depends on the type of cells involved and whether the growth is benign or malignant.
Abnormal Cell Proliferation
Cells multiply without normal regulatory control.
Tumor Expansion
Growth creates a mass within the orbit.
Compression of Structures
The tumor may affect eyelids, muscles, nerves, or the globe.
Possible Invasion
Malignant tumors may extend into surrounding tissues.
Types of Lacrimal Gland Tumors
Lacrimal gland tumors are classified based on their origin and biological behavior.
Benign Lacrimal Gland Tumors
Non-cancerous tumors that typically grow slowly.
Malignant Lacrimal Gland Tumors
Cancerous tumors that may invade surrounding structures.
Epithelial Tumors
Arise from glandular epithelial cells.
Lymphoid Tumors
Develop from immune system cells within the gland.
Inflammatory Lesions
Inflammatory conditions may mimic tumor growth.
Metastatic Lesions
Cancer from another location may spread to the lacrimal gland.
Common Lacrimal Gland Tumor Types
Pleomorphic Adenoma
A common benign epithelial tumor that usually grows slowly.
Adenoid Cystic Carcinoma
A malignant tumor known for aggressive behavior and possible nerve involvement.
Lymphoma
A lymphoid tumor that may involve the lacrimal gland.
Carcinoma Ex Pleomorphic Adenoma
A malignant transformation arising from a previous benign tumor.
Causes & Risk Factors
The exact cause of most lacrimal gland tumors is unknown, but several factors may contribute to abnormal growth.
Genetic Changes
Alterations in cellular DNA may contribute to tumor development.
Age
Certain tumor types are more common in specific age groups.
Immune System Factors
Lymphoid tumors may be associated with immune-related conditions.
Prior Radiation Exposure
Previous radiation may increase risk for some tumors.
Genetic Factors
Cell Mutation
Changes in genes controlling cell growth may contribute.
Tumor Biology
Genetic characteristics influence growth behavior.
Inherited Conditions
Rare inherited syndromes may increase tumor risk.
Inflammatory Associations
Some inflammatory disorders may resemble tumors or contribute to lacrimal gland enlargement.
IgG4-Related Disease
Can cause lacrimal gland enlargement that may mimic a tumor.
Sarcoidosis
May involve lacrimal tissue.
Inflammatory Pseudotumor
A non-cancerous inflammatory process that resembles a mass.
Clinical Appearance
The appearance depends on tumor size, location, and behavior.
Upper Outer Eyelid Fullness
A mass may create visible swelling near the temple side of the eyelid.
Globe Displacement
A growing tumor may push the eye downward or inward.
Proptosis
Large tumors may cause forward displacement of the eye.
Orbital Asymmetry
Changes may be visible between the two eyes.
Symptoms & Clinical Signs
Symptoms of lacrimal gland tumors depend on tumor type, growth rate, size, and whether surrounding orbital structures are affected.
Common Symptoms
- Upper outer eyelid swelling
- Painless orbital fullness
- Progressive eyelid asymmetry
- Feeling of pressure around the eye
- Double vision
- Eye displacement
- Headache or orbital discomfort
Clinical Findings
- Palpable lacrimal gland mass
- Superolateral orbital fullness
- Downward displacement of the globe
- Forward displacement of the eye
- Restricted eye movement in advanced cases
- Optic nerve compression in severe disease
Benign vs Malignant Lacrimal Gland Tumors
The behavior of lacrimal gland tumors varies significantly. Benign tumors usually grow slowly, while malignant tumors may invade surrounding structures.
Benign Tumor Features
- Slow growth over years
- Painless enlargement
- Smooth borders on imaging
- Limited invasion of surrounding tissues
- Usually preserved orbital function
Malignant Tumor Features
- Rapid progression
- Pain or tenderness
- Bone involvement
- Nerve-related symptoms
- Orbital invasion
Slow-Growing vs Rapid-Growing Tumors
Growth pattern provides important clues when evaluating a lacrimal gland mass.
Slow-Growing Tumors
Often associated with benign lesions such as pleomorphic adenoma. Symptoms may develop gradually over several years.
Rapid-Growing Tumors
Rapid enlargement may suggest malignancy, inflammation, or aggressive disease.
Changing Symptoms
New pain, vision changes, or increasing asymmetry require further evaluation.
Unilateral vs Bilateral Lacrimal Gland Disease
Most lacrimal gland tumors are unilateral, but bilateral enlargement may occur with specific conditions.
Unilateral Tumors
- Most common presentation
- Usually affects one lacrimal gland
- May cause visible orbital asymmetry
- Requires evaluation for tumor type
Bilateral Lacrimal Enlargement
- Less typical for primary tumors
- May suggest lymphoma or inflammatory disease
- Requires systemic evaluation
- May involve immune disorders
Pediatric Presentation
Lacrimal gland tumors in children are uncommon but require careful evaluation because orbital lesions can affect vision development.
Orbital Mass
Children may present with visible upper eyelid swelling or eye displacement.
Rapid Changes
Growth over a short period requires prompt assessment.
Vision Impact
Large lesions may affect visual development or eye alignment.
Adult Presentation
Adults represent the majority of lacrimal gland tumor cases and often present with gradual orbital changes.
Progressive Fullness
A slowly enlarging upper eyelid mass is a common presentation.
Orbital Pressure
Patients may describe discomfort or fullness around the eye.
Visual Symptoms
Large tumors may cause double vision or displacement of the eye.
History Evaluation
A detailed history helps distinguish lacrimal gland tumors from inflammatory or structural conditions.
Duration of Symptoms
Long-standing slow growth may suggest benign disease.
Pain Assessment
Pain may raise concern for malignancy or inflammation.
Growth Pattern
Rapid enlargement requires urgent evaluation.
Vision Changes
Double vision or decreased vision may indicate orbital involvement.
Systemic Symptoms
Weight loss, fatigue, or lymph node enlargement may suggest systemic disease.
Previous Cancer History
Important when considering metastatic disease.
Clinical Examination
Examination evaluates the mass, surrounding orbit, ocular function, and visual system.
External Inspection
Assesses eyelid contour and orbital asymmetry.
Palpation
Evaluates size, mobility, tenderness, and consistency.
Ocular Motility
Checks for movement restriction caused by orbital mass effect.
Visual Function Testing
Assesses whether the tumor affects vision.
Orbital Examination
A complete orbital evaluation is essential because the lacrimal gland lies within the confined orbital space.
Globe Position
Evaluates displacement caused by mass effect.
Proptosis Assessment
Measures forward displacement of the eye.
Orbital Signs
Assesses pain, restriction, and surrounding tissue involvement.
Lacrimal Gland Assessment
Evaluation focuses on determining whether enlargement represents a tumor, inflammation, or another process.
Mass Location
Confirms involvement of the lacrimal gland region.
Consistency
Firmness or irregularity may provide diagnostic clues.
Tenderness
Pain may suggest inflammation or aggressive disease.
Associated Findings
Evaluates eyelid, orbital, and ocular effects.
Diagnosis of Lacrimal Gland Tumors
Diagnosis requires clinical evaluation, imaging, and often tissue analysis to determine tumor type.
Clinical Evaluation
Identifies suspicious features based on examination and history.
Imaging Studies
Determine size, location, and relationship to surrounding structures.
Biopsy
Provides definitive diagnosis for many tumors.
Imaging Evaluation
Imaging is essential for characterizing lacrimal gland tumors.
CT Scan
Evaluates bone involvement and orbital anatomy.
MRI
Provides detailed soft tissue evaluation.
Tumor Characteristics
Imaging helps assess borders, invasion, and internal features.
Biopsy Evaluation
Biopsy provides information about the exact tumor type and guides treatment.
Needle Biopsy
May be used in selected cases.
Surgical Biopsy
Provides tissue for detailed pathological evaluation.
Pathology Analysis
Determines whether the lesion is benign, malignant, or inflammatory.
Differential Diagnosis
Several conditions can mimic lacrimal gland tumors.
Dacryoadenitis
Inflammatory enlargement of the lacrimal gland.
Lacrimal Gland Prolapse
Displacement of normal gland tissue.
IgG4-Related Disease
Inflammatory enlargement that may resemble a mass.
Sarcoidosis
Systemic inflammatory disease affecting lacrimal tissue.
Orbital Lymphoma
Lymphoid malignancy involving orbital structures.
Dermoid Cyst
Benign orbital lesion that may present as a mass.
Treatment Options for Lacrimal Gland Tumors
Treatment depends on the tumor type, whether it is benign or malignant, its size, location, and involvement of surrounding orbital structures.
Observation
Selected small, stable lesions may be monitored with clinical examinations and imaging.
Surgical Management
Most lacrimal gland tumors require removal or biopsy to establish diagnosis and treatment.
Medical Oncology
Malignant tumors may require radiation, chemotherapy, or targeted treatments.
Observation of Selected Lesions
Observation may be considered in carefully selected cases when immediate intervention is not required.
Small Stable Lesions
Slow-growing lesions without concerning features may be monitored.
Imaging Surveillance
Periodic imaging evaluates changes in size or characteristics.
Symptom Monitoring
New pain, growth, or vision changes require reassessment.
Surgical Management
Surgery is a primary treatment approach for many lacrimal gland tumors because it provides both diagnosis and removal of abnormal tissue.
Tumor Removal
The goal is complete removal while preserving important orbital structures.
Tissue Diagnosis
Surgical specimens allow accurate pathological classification.
Function Preservation
Protecting vision, eye movement, and tear function is a priority.
Lacrimal Gland Tumor Excision
Excision involves removal of the tumor while attempting to preserve normal orbital anatomy.
Benign Tumors
Complete removal is often curative when the tumor is fully excised.
Malignant Tumors
Removal may require wider margins depending on tumor behavior.
Pathology Assessment
The removed tissue determines further treatment needs.
Orbitotomy Procedures
Orbitotomy refers to surgical approaches used to access lesions within the orbit, including lacrimal gland tumors.
Lateral Orbitotomy
Provides access to tumors located in the lateral orbit.
Anterior Orbital Approach
Used for selected lesions accessible from the front of the orbit.
Surgical Planning
Approach depends on tumor size, location, and anatomy.
Complete Tumor Removal
Complete excision is an important goal, particularly for tumors with malignant potential.
Clear Margins
Removal of surrounding tissue may be needed to reduce recurrence risk.
Avoid Tumor Rupture
Careful handling reduces the risk of spreading tumor cells.
Pathology Confirmation
Final diagnosis guides additional treatment decisions.
Radiation Therapy
Radiation therapy may be used for certain malignant lacrimal gland tumors, especially when complete surgical removal is difficult.
Adjuvant Radiation
May be used after surgery to reduce recurrence risk.
Unresectable Disease
May provide treatment when surgery is not possible.
Specialized Planning
Treatment is designed to protect nearby ocular structures.
Chemotherapy
Chemotherapy may be considered for specific malignant tumors, particularly those involving lymphoid or metastatic disease.
Lymphoma Treatment
Systemic therapy is often used for lymphoid tumors.
Advanced Malignancy
May be used when disease extends beyond the orbit.
Multidisciplinary Care
Treatment often involves oncology specialists.
Immunotherapy & Targeted Therapy
Some tumors may benefit from therapies that specifically target abnormal immune or cellular pathways.
Lymphoid Tumors
Immune-based treatments may be considered in selected lymphomas.
Targeted Treatment
Certain molecular characteristics may guide therapy selection.
Specialist Evaluation
Treatment depends on tumor biology and pathology findings.
Treatment of Specific Lacrimal Gland Tumors
Pleomorphic Adenoma
Usually treated with complete surgical excision to prevent recurrence.
Adenoid Cystic Carcinoma
Often requires aggressive treatment because of invasive behavior.
Lymphoma
Usually managed with systemic therapy and oncology involvement.
Carcinoma Ex Pleomorphic Adenoma
Requires treatment appropriate for malignant transformation.
Surgical Considerations
Preserve Vision
Protection of the optic nerve and visual structures is essential.
Preserve Eye Movement
Extraocular muscles should be protected whenever possible.
Maintain Tear Function
Preservation of remaining lacrimal tissue is important.
Individualized Approach
Treatment depends on tumor characteristics and patient factors.
Complications of Treatment
Dry Eye Disease
Damage to lacrimal tissue may reduce tear production.
Double Vision
Orbital surgery may affect eye movement.
Tumor Recurrence
Some tumors may return despite treatment.
Radiation Effects
Radiation may affect ocular tissues.
Long-Term Surveillance
Regular Imaging
Monitoring helps detect recurrence or progression.
Eye Examinations
Visual function and orbital health should be followed.
Systemic Monitoring
Some tumors require evaluation beyond the orbit.
Multidisciplinary Care
Ophthalmology, oncology, and pathology teams may collaborate.
Complications of Lacrimal Gland Tumors
Complications depend on tumor type, size, location, growth behavior, and whether surrounding orbital structures are involved.
Orbital Complications
- Globe displacement
- Proptosis
- Double vision
- Restricted eye movement
- Orbital pressure symptoms
Visual & Lacrimal Complications
- Reduced vision from compression
- Dry eye symptoms
- Altered tear production
- Ocular surface irritation
- Optic nerve involvement in advanced disease
Complications of Malignant Lacrimal Gland Tumors
Malignant tumors may behave aggressively and affect nearby tissues within the orbit.
Local Invasion
Tumors may extend into muscles, nerves, bone, or surrounding orbital tissues.
Nerve Involvement
Some tumors may cause pain or sensory changes due to nerve invasion.
Recurrence
Some malignant tumors may return after treatment.
Metastatic Spread
Advanced cancers may spread beyond the orbit.
Complications of Benign Lacrimal Gland Tumors
Although benign tumors do not invade like cancers, they can still cause significant orbital effects because of limited space within the orbit.
Mass Effect
Slow growth may gradually displace the eye.
Cosmetic Changes
Upper eyelid fullness or facial asymmetry may develop.
Recurrence
Incomplete removal may increase recurrence risk.
Emergency Warning Signs
Lacrimal gland tumors require urgent evaluation when symptoms suggest rapid progression or orbital compromise.
Rapid Enlargement
Fast growth may indicate aggressive tumor behavior or inflammation.
Vision Loss
Reduced vision may indicate optic nerve or orbital involvement.
New Double Vision
May indicate involvement of orbital muscles.
Severe Pain
Pain may suggest aggressive tumor behavior or inflammation.
Eye Displacement
Increasing proptosis or globe displacement requires assessment.
Neurologic Symptoms
Numbness or weakness around the eye may indicate nerve involvement.
Prognosis
The prognosis of lacrimal gland tumors depends primarily on tumor type, stage, aggressiveness, and completeness of treatment.
Benign Tumors
Many have excellent outcomes after complete removal.
Low-Grade Malignancies
Outcome depends on early diagnosis and appropriate treatment.
Aggressive Tumors
Require specialized treatment and long-term surveillance.
Early Detection
Earlier diagnosis often improves treatment options.
Factors Affecting Outcome
Tumor Type
Different tumors have different biological behaviors.
Tumor Size
Larger tumors may involve more orbital structures.
Invasion Pattern
Extension into bone, nerves, or muscles affects prognosis.
Treatment Timing
Early evaluation may allow more effective management.
Complete Removal
Achieving tumor control improves outcomes.
Long-Term Follow-Up
Surveillance helps identify recurrence early.
Clinical Pearls
- Lacrimal gland tumors should be considered in persistent upper outer orbital fullness.
- Most lacrimal gland tumors are unilateral.
- Slow painless growth often suggests benign disease but still requires evaluation.
- Pain and rapid growth increase concern for malignancy or inflammation.
- Pleomorphic adenoma is a common benign lacrimal gland tumor.
- Adenoid cystic carcinoma is an important malignant lacrimal gland tumor.
- Imaging helps determine tumor characteristics but pathology confirms diagnosis.
- Biopsy and treatment planning should consider the risk of tumor spread.
- Preservation of vision, eye movement, and tear function are important treatment goals.
Common ICD-10 Codes
| Code | Description |
|---|---|
| D31.5 | Benign neoplasm of orbit |
| C69.5 | Malignant neoplasm of lacrimal gland and other parts of orbit |
| D49.89 | Neoplasm of unspecified behavior of other specified sites |
| H05.89 | Other disorders of orbit |
Patient Education: Understanding Lacrimal Gland Tumors
Seek Evaluation
Persistent upper eyelid swelling should be examined by an eye specialist.
Monitor Changes
Rapid growth, pain, or vision changes should be reported.
Complete Follow-Up
Long-term monitoring may be needed after treatment.
Understand Treatment
Management depends on tumor type and individual findings.
Frequently Asked Questions
What is a lacrimal gland tumor?
A lacrimal gland tumor is an abnormal growth arising from the tear-producing gland in the upper outer orbit.
Are all lacrimal gland tumors cancerous?
No. Some are benign, while others are malignant and require more aggressive treatment.
What are common symptoms?
Symptoms may include upper eyelid swelling, orbital fullness, eye displacement, double vision, or pain.
How are lacrimal gland tumors diagnosed?
Diagnosis usually involves examination, imaging, and often biopsy.
Can lacrimal gland tumors be treated?
Yes. Treatment depends on tumor type and may include surgery, radiation, or medical therapy.
Related Eye Conditions
Lacrimal Gland Prolapse
Displacement of normal lacrimal gland tissue that may mimic a mass.
Dacryoadenitis
Inflammation of the lacrimal gland causing enlargement.
Orbital Lymphoma
Lymphoid malignancy involving orbital tissues.
IgG4-Related Disease
Inflammatory condition that can enlarge lacrimal glands.
Orbital Tumors
Other masses affecting structures within the orbit.
Dry Eye Disease
Ocular surface disorder related to tear dysfunction.
Medical Disclaimer
The information provided by Kardia Vision is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
Patients experiencing persistent orbital swelling, rapid growth, pain, vision changes, or eye displacement should seek evaluation from a qualified eye care professional.
Kardia Vision provides evidence-based eye health education for patients, students, and healthcare professionals.